Neurology

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 6,…

Treatment with DYNE-251 revealed dose dependent exon skipping and dystrophin expression as well as improvement…

Tanya, a patient who lost her mobility due to undiagnosed spinal issues, discussed her life-saving…

The global head of neurology development at Sanofi provided insight on how tolebrutinib may overcome…

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Imad Najm, MD,…

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of…

Based on the positive topline data, the company plans to submit for regulatory approval for…

Treatment with vutrisiran was associated with benefits across multiple well-established clinical measures of disease progression…

The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute provided commentary…

MRI scans showed that 99% of fenebrutinib-treated patients were free of T1 gadolinium-enhancing lesions, indicating…